Skip to content

HIV causes mitochondrial toxicity, even in absence of drugs

Nevirapine safe and effective in patients with a CD4 cell count below 200

New, accurate TB test approved for use in Europe

Cambodian study of tenofovir for HIV prevention halted, PM cites `human rights`

Drug-resistant HIV acquired during infection may persist for up to seven years

South Africa forces recall of Cipla’s Duovir in response to WHO concerns

Importance of biopsies for confirming cause of muscle disease in HIV patients shown by case reports

Rifampicin and pyrazinamide treatment for latent TB in HIV patients does not carry high risk of liver injury, but editorial still urges caution

A rare human genetic make-up gives the best chance against HIV